Research
Hormonal
The weight loss program reduced insomnia symptoms by -17.1 ± 7.4 (p = 0.03; d = -0.30) compared to the waitlist control group.
Weight loss interventions may be beneficial for improving sleep quality in cancer survivors.
StrongSupportsmedium confidence
The weight loss program improved physical functioning and reduced insomnia symptoms (-17.1 ± 7.4; p = 0.03; d = -0.30).
Why this rating
Based on the randomized controlled trial design.
Source
The effects of a clinic‐based weight loss program on health‐related quality of life and weight maintenance in cancer survivors: A randomized controlled trial
Justin C. Brown et al. · Psycho-Oncology · 2021
DOI 10.1002/pon.5817
rct · n=60Cited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →